Emerging Therapies
Aims
The aims of the Emerging Therapies Special Interest Group are to:
- inform within and outside of IHS on novel emerging therapies in headache
- ensure that emerging therapies are tested for safety and efficacy following the same standards as those applied for drug trials
- elaborate, if needed, clinical trial guidelines adapted to emerging therapies like the neurostimulation methods
- liaise with other bodies interested in emerging therapies like the International Neuromodulation Society or the IASP SIG on Neuromodulation
- advise the scientific programme committee of International Headache Congresses about emerging therapies
Members
Chair
Secretary: Delphine Magis
Members
- Anna Ambrosini
- Anna Andreou
- Peter Goadsby
- Jan Hoffmann
- Rigmor Jensen
- Elizabeth Leroux
- Jean Schoenen
- Todd Schwedt
- Stewart Tepper
- Shuu-Jiun Wang